sulbactam has been researched along with Bullous Dermatoses in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bröcker, EB; Rose, C; Shimanovich, I; Sitaru, C; Zillikens, D | 1 |
| Chiu, DS; Phung, TL; Pipkin, CA; Tahan, SR | 1 |
| Fischer, M; Gaber, G; Helmbold, P; Marsch, WCh; Meiss, F; Meykadeh, N | 1 |
3 other study(ies) available for sulbactam and Bullous Dermatoses
| Article | Year |
|---|---|
Localized linear IgA disease induced by ampicillin/sulbactam.
Topics: Aged; Ampicillin; Anti-Bacterial Agents; Autoantibodies; Autoantigens; Autoimmune Diseases; Biopsy; Carrier Proteins; Collagen Type XVII; Cytoskeletal Proteins; Drug Eruptions; Dystonin; Humans; Immunoglobulin A; Male; Nerve Tissue Proteins; Non-Fibrillar Collagens; Skin; Skin Diseases, Vesiculobullous; Sulbactam | 2004 |
Beta-lactam antibiotic-induced pseudoporphyria.
Topics: Abdominal Abscess; Ampicillin; Anemia, Hemolytic, Autoimmune; Anti-Bacterial Agents; Biopsy; Fallopian Tube Diseases; Female; Forehead; Humans; Kidney Failure, Chronic; Leukocyte Count; Lupus Erythematosus, Systemic; Middle Aged; Ovarian Diseases; Pruritus; Renal Dialysis; Sickle Cell Trait; Skin; Skin Diseases, Vesiculobullous; Sulbactam; Thrombocytopenia | 2004 |
Overlap of acute generalized exanthematous pustulosis and toxic epidermal necrolysis: response to antitumour necrosis factor-alpha antibody infliximab: report of three cases.
Topics: Acute Disease; Adult; Amoxicillin; Ampicillin; Antibodies, Monoclonal; Clindamycin; Dermatologic Agents; Drug Eruptions; Female; Humans; Infliximab; Male; Middle Aged; Skin Diseases, Vesiculobullous; Stevens-Johnson Syndrome; Sulbactam | 2007 |